A randomized, double blind, parallel group, placebo controlled trial of Exenatide once weekly over 2 years as a potential disease modifying treatment for moderate severity Parkinson's disease

Project: Research

Project Details


PI change from Dr Marios Politis to Prof Ray Chaudhuri, Nov 2019
Budget allocation (from DA to DI) change approved by NIHR 16 03 2020
Short titleEXENATIDE
Effective start/end date1/01/201931/12/2023

Collaborative partners


  • NIHR National Institute For Health & Care Research: £47,402.11


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.